YKL-40 and CRP had similar prognostic abilities for obesity-related and gastrointestinal cancers, but YKL-40 outperformed CRP for liver and bladder cancers. The gene discussed is CHI3L1; the disease is obesity due to melanocortin 4 receptor deficiency.